News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

West (WST) Introduces the NovaGuard(TM) Safety Needle System



7/28/2009 1:07:43 PM

West (NYSE: WST), the global leader in innovative solutions for injectable drug administration, has introduced the NovaGuard system, a passive safety needle compatible with Luer Lock syringes. The NovaGuard system, designed to help mitigate the risk of accidental needlestick injuries, is 510k-cleared by the U.S. Food and Drug Administration.

With the NovaGuard system, a plastic shield surrounds the needle before the injection is given, leaving only the needle tip exposed for injection site orientation. When the needle is pressed on the patient’s skin to administer the injection, the protective shield is activated. As the needle is withdrawn, the shield extends forward to cover the needle fully and the shield is locked in place. Unlike “active” needle safety devices, the NovaGuard system provides a safety feature without changing standard injection practices, and requires no extra steps to activate the safety feature.

“The innovative NovaGuard system provides the market with a truly passive safety needle system that can be attached by the user to a Luer Lock syringe,” said Graham Reynolds, Vice President, Innovation Strategic Marketing at West. “This product adds to West’s established solutions aimed at enhancing the safety, convenience and effectiveness of drug preparation and administration.”

Extensive field testing with nurses helped optimize the design of the NovaGuard system. These tests demonstrated the system’s intuitive, dependable and easy-to-use self-activated operation.

The NovaGuard system benefits health care practitioners, patients and pharmaceutical companies.

• For health care practitioners, the NovaGuard system is easy to use, without any change to drug administration technique. The NovaGuard system can also help reduce needlestick injuries and improve OSHA compliance.

• For patients, injections given with the NovaGuard system can be less threatening because the needle is covered throughout the procedure.

• For pharmaceutical companies, the NovaGuard system does not require any changes to their manufacturing processes and can help compliance with safety standards, such as those required by OSHA.

The Tech Group, a West company, manufactures the NovaGuard system at its facility in Montgomery, Pa.

A video demonstration of the NovaGuard system is available at WestNovaGuard.com.

About West

West is a global manufacturer of components and systems for injectable drug delivery, including stoppers and seals for vials, and closures and disposable components used in syringe, IV and blood collection systems. The Company also provides products with application to the personal care, food and beverage markets. Headquartered in Lionville, Pennsylvania, West supports its partners and customers from 50 locations throughout North America, South America, Europe, Mexico, Japan, Asia and Australia. For more information, visit West at www.westpharma.com.

NovaGuard™ is a trademark of West Pharmaceutical Services, Inc. in the United States and other jurisdictions.

Read at BioSpace.com


comments powered by Disqus
West
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES